BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18787424)

  • 1. Role of nitric oxide in P. aeruginosa keratitis caused by distinct bacterial phenotypes.
    Wang W; Xue M; Willcox M; Thakur A
    Eye Contact Lens; 2008 Jul; 34(4):195-7. PubMed ID: 18787424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.
    Huang X; Du W; McClellan SA; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4910-6. PubMed ID: 17065506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
    Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of nitric oxide in resistance to P. aeruginosa ocular infection.
    Hazlett LD; McClellan S; Goshgarian C; Huang X; Thakur A; Barrett R
    Ocul Immunol Inflamm; 2005; 13(4):279-88. PubMed ID: 16159718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pseudomonas aeruginosa strain isolated from a contact lens-induced acute red eye (CLARE) is protease-deficient.
    Estrellas PS; Alionte LG; Hobden JA
    Curr Eye Res; 2000 Mar; 20(3):157-65. PubMed ID: 10694889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model.
    Cole N; Willcox MD; Fleiszig SM; Stapleton F; Bao B; Tout S; Husband A
    Curr Eye Res; 1998 Jul; 17(7):730-5. PubMed ID: 9678419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
    Karicherla P; Hobden JA
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):256-62. PubMed ID: 18775859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma: regulation of nitric oxide in the P. aeruginosa-infected cornea.
    McClellan SA; Lighvani S; Hazlett LD
    Ocul Immunol Inflamm; 2006 Feb; 14(1):21-8. PubMed ID: 16507487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Pseudomonas aeruginosa ExsA in penetration through corneal epithelium in a novel in vivo model.
    Lee EJ; Evans DJ; Fleiszig SM
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5220-7. PubMed ID: 14638720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide outer core is a ligand for corneal cell binding and ingestion of Pseudomonas aeruginosa.
    Zaidi TS; Fleiszig SM; Preston MJ; Goldberg JB; Pier GB
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):976-86. PubMed ID: 8631641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.
    Kernacki KA; Barrett R; Hazlett LD
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy of a peptide derived from a potential adhesin of Pseudomonas aeruginosa against corneal infection.
    Yuan Q; Wu Y; Wang Y; Chen L; Qu M; Duan K; Zhao G
    Exp Eye Res; 2016 Feb; 143():39-48. PubMed ID: 26500187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence.
    Engel LS; Hill JM; Moreau JM; Green LC; Hobden JA; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):662-5. PubMed ID: 9501882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Pseudomonas aeruginosa corneal infection in IL-1 beta converting enzyme (ICE, caspase-1) deficient mice.
    Thakur A; Barrett RP; McClellan S; Hazlett LD
    Curr Eye Res; 2004; 29(4-5):225-33. PubMed ID: 15590467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-4 is not critical to pathogenesis in a mouse model of Pseudomonas aeruginosa corneal infection.
    Cole N; Hume E; Khan S; Krockenberger M; Thakur A; Husband AJ; Willcox MD
    Curr Eye Res; 2005 Jul; 30(7):535-42. PubMed ID: 16020287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aged mice fail to upregulate ICAM-1 after Pseudomonas aeruginosa corneal infection.
    Hobden JA; Masinick SA; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1107-14. PubMed ID: 7730020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkaline protease-deficient mutants of Pseudomonas aeruginosa are virulent in the eye.
    Pillar CM; Hazlett LD; Hobden JA
    Curr Eye Res; 2000 Sep; 21(3):730-9. PubMed ID: 11120561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
    McClellan SA; Zhang Y; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1502-11. PubMed ID: 18385069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyphosphate kinase 1 and the ocular virulence of Pseudomonas aeruginosa.
    Parks QM; Hobden JA
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):248-51. PubMed ID: 15623780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.